BPC-157 vs. TB-500: A Research Peptide Comparison

Summary: BPC-157 and TB-500 are two peptides frequently studied together in preclinical tissue-repair research, but they are structurally and mechanistically distinct. This overview compares them as research compounds.

BPC-157

BPC-157 is a synthetic peptide based on a sequence found in a gastric protein. In preclinical and in-vitro studies it is investigated for pathways related to angiogenesis and tissue repair. NGP carries BPC-157.

TB-500

TB-500 is a synthetic fragment of the protein thymosin beta-4. Research interest centers on its role in actin regulation and cell migration in laboratory models. NGP carries TB-500.

Key differences

BPC-157 derives from a gastric peptide sequence and is studied around angiogenesis pathways; TB-500 is a thymosin beta-4 fragment studied around actin-binding and cell-migration mechanisms. Because their proposed mechanisms differ, they are sometimes studied in combination — which is why blended research preparations exist.

Sourcing

Both are identity- and purity-tested by ILS Labs (ISO/IEC 17025), with batch COAs in the COA Library. Explore the full range in the shop.

All products are supplied strictly for laboratory and in-vitro research use only (RUO). They are not intended for human or veterinary use, and no dosing or administration guidance is provided.